Currently out of the existing stock ratings of Timur Ivannikov, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).
Analyst Timur Ivannikov, currently employed at RAYMOND JAMES, has had 25% of price targets met with an average potential upside of 16.03%, reached in 80 days on average.
Timur Ivannikov has documented 10 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RCKT, Rocket Pharmaceuticals at 05-May-2023.
Analyst best performing recommendations are on RCKT (ROCKET PHARMACEUTICALS).
The best stock recommendation documented was for RCKT (ROCKET PHARMACEUTICALS) on 7/8/2022. The price target of $22 was fulfilled within 159 days with a profit of $5.34 (32.05%), with a performance score of 2.02.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$7.5
4 years 6 days ago
(16-Nov-2022)
1/1 (100%)
$-5.25 (-41.18%)
29
Hold
4 years 7 days ago
(15-Nov-2022)
0/2 (0%)
$271.75 (107.31%)
Buy
$50
$175
4 years 3 months 6 days ago
(16-Aug-2022)
0/2 (0%)
$19.25 (62.60%)
Stocks Timur Ivannikov covered previously. Scores are shown for active stocks only.
The record of these past calls is part of the data set at anachart.store.
What Year was the first public recommendation made by Timur Ivannikov?